News
Archive
New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence
NorthSea Therapeutics reports Positive Phase 2b interim results for icosabutate in NASH patients
Resolve Therapeutics announces clinically meaningful improvement in patients with Systemic lupus erythematosus in Phase 2a clinical trial
Resolve Therapeutics publishes positive Sjogren’s syndrome clinical trial results
NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline
ProterixBio Announces Commercial Availability of a Semi-Quantitative COVID-19 Antibody Test
Back To News

January 31, 2018
Our CMO talks solutions and projects
Aashu Virmani, Fuzzy Logix’ CMO was interviewed recently by independent analyst and industry expert, Ron Powell. He discusses how machine learning applies to anti-money laundering using decision trees, regression and neural nets, explains indexed data management, and gives a glimpse of 2018’s exciting new projects. Listen to the podcast.
The post Our CMO talks solutions and projects appeared first on Fuzzy Logix.